Bingyu Wang1, Ki-Do Eum2, Fatemeh Kazemiparkouhi2, Cheng Li3, Justin Manjourides4, Virgil Pavlu3, Helen Suh2. 1. Khoury College of Computer Sciences, Northeastern University, 440 Huntington Ave, Boston, MA, 02115, USA. rainicy@ccs.neu.edu. 2. Department of Civil & Environmental Engineering, Tufts University, Medford, MA, USA. 3. Khoury College of Computer Sciences, Northeastern University, 440 Huntington Ave, Boston, MA, 02115, USA. 4. Bouvè College of Health Sciences, Northeastern University, Boston, MA, USA.
Abstract
BACKGROUND: The shape of the exposure-response curve for long-term ambient fine particulate (PM2.5) exposure and cause-specific mortality is poorly understood, especially for rural populations and underrepresented minorities. METHODS: We used hybrid machine learning and Cox proportional hazard models to assess the association of long-term PM2.5 exposures on specific causes of death for 53 million U.S. Medicare beneficiaries (aged ≥65) from 2000 to 2008. Models included strata for age, sex, race, and ZIP code and controlled for neighborhood socio-economic status (SES) in our main analyses, with approximately 4 billion person-months of follow-up, and additionally for warm season average of 1-h daily maximum ozone exposures in a sensitivity analysis. The impact of non-traffic PM2.5 on mortality was examined using two stage models of PM2.5 and nitrogen dioxide (NO2). RESULTS: A 10 μg /m3 increase in 12-month average PM2.5 prior to death was associated with a 5% increase in all-cause mortality, as well as an 8.8, 5.6, and 2.5% increase in all cardiovascular disease (CVD)-, all respiratory-, and all cancer deaths, respectively, in age, gender, race, ZIP code, and SES-adjusted models. PM2.5 exposures, however, were not associated with lung cancer mortality. Results were not sensitive to control for ozone exposures. PM2.5-mortality associations for CVD- and respiratory-related causes were positive and significant for beneficiaries irrespective of their sex, race, age, SES and urbanicity, with no evidence of a lower threshold for response or of lower Risk Ratios (RRs) at low PM2.5 levels. Associations between PM2.5 and CVD and respiratory mortality were linear and were higher for younger, Black and urban beneficiaries, but were largely similar by SES. Risks associated with non-traffic PM2.5 were lower than that for all PM2.5 and were null for respiratory and lung cancer-related deaths. CONCLUSIONS: PM2.5 was associated with mortality from CVD, respiratory, and all cancer, but not lung cancer. PM2.5-associated risks of CVD and respiratory mortality were similar across PM2.5 levels, with no evidence of a threshold. Blacks, urban, and younger beneficiaries were most vulnerable to the long-term impacts of PM2.5 on mortality.
BACKGROUND: The shape of the exposure-response curve for long-term ambient fine particulate (PM2.5) exposure and cause-specific mortality is poorly understood, especially for rural populations and underrepresented minorities. METHODS: We used hybrid machine learning and Cox proportional hazard models to assess the association of long-term PM2.5 exposures on specific causes of death for 53 million U.S. Medicare beneficiaries (aged ≥65) from 2000 to 2008. Models included strata for age, sex, race, and ZIP code and controlled for neighborhood socio-economic status (SES) in our main analyses, with approximately 4 billion person-months of follow-up, and additionally for warm season average of 1-h daily maximum ozone exposures in a sensitivity analysis. The impact of non-traffic PM2.5 on mortality was examined using two stage models of PM2.5 and nitrogen dioxide (NO2). RESULTS: A 10 μg /m3 increase in 12-month average PM2.5 prior to death was associated with a 5% increase in all-cause mortality, as well as an 8.8, 5.6, and 2.5% increase in all cardiovascular disease (CVD)-, all respiratory-, and all cancer deaths, respectively, in age, gender, race, ZIP code, and SES-adjusted models. PM2.5 exposures, however, were not associated with lung cancer mortality. Results were not sensitive to control for ozone exposures. PM2.5-mortality associations for CVD- and respiratory-related causes were positive and significant for beneficiaries irrespective of their sex, race, age, SES and urbanicity, with no evidence of a lower threshold for response or of lower Risk Ratios (RRs) at low PM2.5 levels. Associations between PM2.5 and CVD and respiratory mortality were linear and were higher for younger, Black and urban beneficiaries, but were largely similar by SES. Risks associated with non-traffic PM2.5 were lower than that for all PM2.5 and were null for respiratory and lung cancer-related deaths. CONCLUSIONS:PM2.5 was associated with mortality from CVD, respiratory, and all cancer, but not lung cancer. PM2.5-associated risks of CVD and respiratory mortality were similar across PM2.5 levels, with no evidence of a threshold. Blacks, urban, and younger beneficiaries were most vulnerable to the long-term impacts of PM2.5 on mortality.
Entities:
Keywords:
Air pollution; Cancer mortality; Cardiovascular disease mortality; Chronic exposure; Environmental epidemiology; PM2.5; Respiratory disease mortality
Authors: Seulkee Heo; Ji-Young Son; Chris C Lim; Kelvin C Fong; Hayon Michelle Choi; Raul U Hernandez-Ramirez; Kate Nyhan; Preet K Dhillon; Suhela Kapoor; Dorairaj Prabhakaran; Donna Spiegelman; Michelle L Bell Journal: Environ Res Lett Date: 2022-05-16 Impact factor: 6.947
Authors: Alimata Sidibe; Yosuke Sakamoto; Kentaro Murano; Ousmane A Koita; Ibrahim Traore; Yacouba Dansoko; Yoshizumi Kajii Journal: Int J Environ Res Public Health Date: 2022-01-05 Impact factor: 3.390
Authors: Mike Z He; Vivian Do; Siliang Liu; Patrick L Kinney; Arlene M Fiore; Xiaomeng Jin; Nicholas DeFelice; Jianzhao Bi; Yang Liu; Tabassum Z Insaf; Marianthi-Anna Kioumourtzoglou Journal: Environ Health Date: 2021-08-23 Impact factor: 5.984
Authors: Michelle C Turner; Zorana J Andersen; Andrea Baccarelli; W Ryan Diver; Susan M Gapstur; C Arden Pope; Diddier Prada; Jonathan Samet; George Thurston; Aaron Cohen Journal: CA Cancer J Clin Date: 2020-08-25 Impact factor: 508.702
Authors: Bertha V Vasquez-Apestegui; Enrique Parras-Garrido; Vilma Tapia; Valeria M Paz-Aparicio; Jhojan P Rojas; Odón R Sanchez-Ccoyllo; Gustavo F Gonzales Journal: BMC Public Health Date: 2021-06-16 Impact factor: 4.135